These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

621 related items for PubMed ID: 15990678

  • 1. MSG-1 expression in benign and malignant melanocytic lesions of cutaneous and mucosal epithelium.
    Sedghizadeh PP, Williams JD, Allen CM, Prasad ML.
    Med Sci Monit; 2005 Jul; 11(7):BR189-94. PubMed ID: 15990678
    [Abstract] [Full Text] [Related]

  • 2. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
    Boyd AS, Shakhtour B, Shyr Y.
    J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
    [Abstract] [Full Text] [Related]

  • 3. Expression of the ets-1 proto-oncogene in melanocytic lesions.
    Keehn CA, Smoller BR, Morgan MB.
    Mod Pathol; 2003 Aug; 16(8):772-7. PubMed ID: 12920221
    [Abstract] [Full Text] [Related]

  • 4. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
    Demirkan NC, Kesen Z, Akdag B, Larue L, Delmas V.
    Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
    [Abstract] [Full Text] [Related]

  • 5. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
    Nasr MR, El-Zammar O.
    Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
    [Abstract] [Full Text] [Related]

  • 6. Cyclin D1 expression in melanocytic lesions of the skin.
    Ramirez JA, Guitart J, Rao MS, Diaz LK.
    Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
    [Abstract] [Full Text] [Related]

  • 7. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
    Nazarian RM, Prieto VG, Elder DE, Duncan LM.
    J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
    Simonetti O, Lucarini G, Brancorsini D, Nita P, Bernardini ML, Biagini G, Offidani A.
    Cancer; 2002 Nov 01; 95(9):1963-70. PubMed ID: 12404291
    [Abstract] [Full Text] [Related]

  • 9. Nucleolin protein expression in cutaneous melanocytic lesions.
    Mourmouras V, Cevenini G, Cosci E, Epistolato MC, Biagioli M, Barbagli L, Luzi P, Mannucci S, Miracco C.
    J Cutan Pathol; 2009 Jun 01; 36(6):637-46. PubMed ID: 19515042
    [Abstract] [Full Text] [Related]

  • 10. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma.
    Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M.
    Clin Cancer Res; 2006 Nov 15; 12(22):6709-15. PubMed ID: 17121890
    [Abstract] [Full Text] [Related]

  • 11. Fascin expression in melanocytic lesions of the skin.
    YILDIZ L, KEFELI M, AYDIN O, KANDEMIR B.
    Eur J Dermatol; 2009 Nov 15; 19(5):445-50. PubMed ID: 19527987
    [Abstract] [Full Text] [Related]

  • 12. Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma.
    Tron VA, Krajewski S, Klein-Parker H, Li G, Ho VC, Reed JC.
    Am J Pathol; 1995 Mar 15; 146(3):643-50. PubMed ID: 7534042
    [Abstract] [Full Text] [Related]

  • 13. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
    Miracco C, De Nisi MC, Arcuri F, Cosci E, Pacenti L, Toscano M, Lalinga AV, Biagioli M, Rubegni P, Vatti R, Maellaro E, Del Bello B, Massi D, Luzi P, Tosi P.
    Int J Oncol; 2006 Feb 15; 28(2):345-52. PubMed ID: 16391788
    [Abstract] [Full Text] [Related]

  • 14. Expression of heat shock protein 105 and 70 in malignant melanoma and benign melanocytic nevi.
    Park HS, Park CH, Choi BR, Lim MS, Heo SH, Kim CH, Kang SG, Whang KU, Cho MK.
    J Cutan Pathol; 2009 May 15; 36(5):511-6. PubMed ID: 19476517
    [Abstract] [Full Text] [Related]

  • 15. S100A6 protein expression is different in Spitz nevi and melanomas.
    Ribé A, McNutt NS.
    Mod Pathol; 2003 May 15; 16(5):505-11. PubMed ID: 12748257
    [Abstract] [Full Text] [Related]

  • 16. Histopathological characteristics of malignant melanoma affecting mucous membranes: a unifying concept of histogenesis.
    Saida T, Kawachi S, Takata M, Kurita H, Kurashina K, Kageshita T, Tonogi M, Okazaki Y, Yamane GY, Takubo K, Ueyama Y.
    Pathology; 2004 Oct 15; 36(5):404-13. PubMed ID: 15370109
    [Abstract] [Full Text] [Related]

  • 17. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression.
    Montone KT, van Belle P, Elenitsas R, Elder DE.
    Mod Pathol; 1997 Sep 15; 10(9):939-44. PubMed ID: 9310959
    [Abstract] [Full Text] [Related]

  • 18. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E, Vizoso F, Martín A, Quintela I, Corte MD, Seguí ME, Ordiz I, Merino AM.
    J Surg Oncol; 2003 Jun 15; 83(2):99-105. PubMed ID: 12772203
    [Abstract] [Full Text] [Related]

  • 19. [Expression of galanin in melanocytic tumors].
    Gilaberte Y, Vera J, Coscojuela C, Roca MJ, Parrado C, González S.
    Actas Dermosifiliogr; 2007 Jun 15; 98(1):24-34. PubMed ID: 17374330
    [Abstract] [Full Text] [Related]

  • 20. Immunoreactivity with the anti-MAGE antibody 57B in malignant melanoma: frequency of expression and correlation with prognostic parameters.
    Busam KJ, Iversen K, Berwick M, Spagnoli GC, Old LJ, Jungbluth AA.
    Mod Pathol; 2000 Apr 15; 13(4):459-65. PubMed ID: 10786815
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.